COVID-19 Impact on Global Allergic Rhinitis Immunotherapies Market Size, Status and Forecast 2020-2026
Allergic rhinitis, sometimes referred to as hay fever, is an inflammatory disease that causes sneezing, itchy or watery eyes, itchy or runny nose and congestion.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Allergic Rhinitis Immunotherapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Allergic Rhinitis Immunotherapies industry.
Based on our recent survey, we have several different scenarios about the Allergic Rhinitis Immunotherapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Allergic Rhinitis Immunotherapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Allergic Rhinitis Immunotherapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Allergic Rhinitis Immunotherapies market in terms of revenue.
Players, stakeholders, and other participants in the global Allergic Rhinitis Immunotherapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Allergic Rhinitis Immunotherapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Allergic Rhinitis Immunotherapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Allergic Rhinitis Immunotherapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Allergic Rhinitis Immunotherapies market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Allergic Rhinitis Immunotherapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Allergic Rhinitis Immunotherapies industry.
Based on our recent survey, we have several different scenarios about the Allergic Rhinitis Immunotherapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Allergic Rhinitis Immunotherapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Allergic Rhinitis Immunotherapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Allergic Rhinitis Immunotherapies market in terms of revenue.
Players, stakeholders, and other participants in the global Allergic Rhinitis Immunotherapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Allergic Rhinitis Immunotherapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Allergic Rhinitis Immunotherapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Allergic Rhinitis Immunotherapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Allergic Rhinitis Immunotherapies market.
The following players are covered in this report:
- Anergis
- HAL Allergy Group
- Merck
- Allergy Therapeutics
- ALK-Abello
- Stallergenes Greer
- Laboratorios LETI
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Allergic Rhinitis Immunotherapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Allergic Rhinitis Immunotherapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Subcutaneous Immunotherapy
1.4.3 Sublingual Immunotherapy
1.5 Market by Application
1.5.1 Global Allergic Rhinitis Immunotherapies Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Allergic Rhinitis Immunotherapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Allergic Rhinitis Immunotherapies Industry
1.6.1.1 Allergic Rhinitis Immunotherapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Allergic Rhinitis Immunotherapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Allergic Rhinitis Immunotherapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Allergic Rhinitis Immunotherapies Market Perspective (2015-2026)
2.2 Allergic Rhinitis Immunotherapies Growth Trends by Regions
2.2.1 Allergic Rhinitis Immunotherapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Allergic Rhinitis Immunotherapies Historic Market Share by Regions (2015-2020)
2.2.3 Allergic Rhinitis Immunotherapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Allergic Rhinitis Immunotherapies Market Growth Strategy
2.3.6 Primary Interviews with Key Allergic Rhinitis Immunotherapies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Allergic Rhinitis Immunotherapies Players by Market Size
3.1.1 Global Top Allergic Rhinitis Immunotherapies Players by Revenue (2015-2020)
3.1.2 Global Allergic Rhinitis Immunotherapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Allergic Rhinitis Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Allergic Rhinitis Immunotherapies Market Concentration Ratio
3.2.1 Global Allergic Rhinitis Immunotherapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Allergic Rhinitis Immunotherapies Revenue in 2019
3.3 Allergic Rhinitis Immunotherapies Key Players Head office and Area Served
3.4 Key Players Allergic Rhinitis Immunotherapies Product Solution and Service
3.5 Date of Enter into Allergic Rhinitis Immunotherapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Allergic Rhinitis Immunotherapies Historic Market Size by Type (2015-2020)
4.2 Global Allergic Rhinitis Immunotherapies Forecasted Market Size by Type (2021-2026)
5 ALLERGIC RHINITIS IMMUNOTHERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
5.2 Global Allergic Rhinitis Immunotherapies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Allergic Rhinitis Immunotherapies Market Size (2015-2020)
6.2 Allergic Rhinitis Immunotherapies Key Players in North America (2019-2020)
6.3 North America Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
6.4 North America Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Allergic Rhinitis Immunotherapies Market Size (2015-2020)
7.2 Allergic Rhinitis Immunotherapies Key Players in Europe (2019-2020)
7.3 Europe Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
7.4 Europe Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
8 CHINA
8.1 China Allergic Rhinitis Immunotherapies Market Size (2015-2020)
8.2 Allergic Rhinitis Immunotherapies Key Players in China (2019-2020)
8.3 China Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
8.4 China Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Allergic Rhinitis Immunotherapies Market Size (2015-2020)
9.2 Allergic Rhinitis Immunotherapies Key Players in Japan (2019-2020)
9.3 Japan Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
9.4 Japan Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Allergic Rhinitis Immunotherapies Market Size (2015-2020)
10.2 Allergic Rhinitis Immunotherapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
10.4 Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
11 INDIA
11.1 India Allergic Rhinitis Immunotherapies Market Size (2015-2020)
11.2 Allergic Rhinitis Immunotherapies Key Players in India (2019-2020)
11.3 India Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
11.4 India Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Allergic Rhinitis Immunotherapies Market Size (2015-2020)
12.2 Allergic Rhinitis Immunotherapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
12.4 Central & South America Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Anergis
13.1.1 Anergis Company Details
13.1.2 Anergis Business Overview and Its Total Revenue
13.1.3 Anergis Allergic Rhinitis Immunotherapies Introduction
13.1.4 Anergis Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020))
13.1.5 Anergis Recent Development
13.2 HAL Allergy Group
13.2.1 HAL Allergy Group Company Details
13.2.2 HAL Allergy Group Business Overview and Its Total Revenue
13.2.3 HAL Allergy Group Allergic Rhinitis Immunotherapies Introduction
13.2.4 HAL Allergy Group Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.2.5 HAL Allergy Group Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview and Its Total Revenue
13.3.3 Merck Allergic Rhinitis Immunotherapies Introduction
13.3.4 Merck Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Allergy Therapeutics
13.4.1 Allergy Therapeutics Company Details
13.4.2 Allergy Therapeutics Business Overview and Its Total Revenue
13.4.3 Allergy Therapeutics Allergic Rhinitis Immunotherapies Introduction
13.4.4 Allergy Therapeutics Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.4.5 Allergy Therapeutics Recent Development
13.5 ALK-Abello
13.5.1 ALK-Abello Company Details
13.5.2 ALK-Abello Business Overview and Its Total Revenue
13.5.3 ALK-Abello Allergic Rhinitis Immunotherapies Introduction
13.5.4 ALK-Abello Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.5.5 ALK-Abello Recent Development
13.6 Stallergenes Greer
13.6.1 Stallergenes Greer Company Details
13.6.2 Stallergenes Greer Business Overview and Its Total Revenue
13.6.3 Stallergenes Greer Allergic Rhinitis Immunotherapies Introduction
13.6.4 Stallergenes Greer Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.6.5 Stallergenes Greer Recent Development
13.7 Laboratorios LETI
13.7.1 Laboratorios LETI Company Details
13.7.2 Laboratorios LETI Business Overview and Its Total Revenue
13.7.3 Laboratorios LETI Allergic Rhinitis Immunotherapies Introduction
13.7.4 Laboratorios LETI Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.7.5 Laboratorios LETI Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Allergic Rhinitis Immunotherapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Allergic Rhinitis Immunotherapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Subcutaneous Immunotherapy
1.4.3 Sublingual Immunotherapy
1.5 Market by Application
1.5.1 Global Allergic Rhinitis Immunotherapies Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Allergic Rhinitis Immunotherapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Allergic Rhinitis Immunotherapies Industry
1.6.1.1 Allergic Rhinitis Immunotherapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Allergic Rhinitis Immunotherapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Allergic Rhinitis Immunotherapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Allergic Rhinitis Immunotherapies Market Perspective (2015-2026)
2.2 Allergic Rhinitis Immunotherapies Growth Trends by Regions
2.2.1 Allergic Rhinitis Immunotherapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Allergic Rhinitis Immunotherapies Historic Market Share by Regions (2015-2020)
2.2.3 Allergic Rhinitis Immunotherapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Allergic Rhinitis Immunotherapies Market Growth Strategy
2.3.6 Primary Interviews with Key Allergic Rhinitis Immunotherapies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Allergic Rhinitis Immunotherapies Players by Market Size
3.1.1 Global Top Allergic Rhinitis Immunotherapies Players by Revenue (2015-2020)
3.1.2 Global Allergic Rhinitis Immunotherapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Allergic Rhinitis Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Allergic Rhinitis Immunotherapies Market Concentration Ratio
3.2.1 Global Allergic Rhinitis Immunotherapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Allergic Rhinitis Immunotherapies Revenue in 2019
3.3 Allergic Rhinitis Immunotherapies Key Players Head office and Area Served
3.4 Key Players Allergic Rhinitis Immunotherapies Product Solution and Service
3.5 Date of Enter into Allergic Rhinitis Immunotherapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Allergic Rhinitis Immunotherapies Historic Market Size by Type (2015-2020)
4.2 Global Allergic Rhinitis Immunotherapies Forecasted Market Size by Type (2021-2026)
5 ALLERGIC RHINITIS IMMUNOTHERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
5.2 Global Allergic Rhinitis Immunotherapies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Allergic Rhinitis Immunotherapies Market Size (2015-2020)
6.2 Allergic Rhinitis Immunotherapies Key Players in North America (2019-2020)
6.3 North America Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
6.4 North America Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Allergic Rhinitis Immunotherapies Market Size (2015-2020)
7.2 Allergic Rhinitis Immunotherapies Key Players in Europe (2019-2020)
7.3 Europe Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
7.4 Europe Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
8 CHINA
8.1 China Allergic Rhinitis Immunotherapies Market Size (2015-2020)
8.2 Allergic Rhinitis Immunotherapies Key Players in China (2019-2020)
8.3 China Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
8.4 China Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Allergic Rhinitis Immunotherapies Market Size (2015-2020)
9.2 Allergic Rhinitis Immunotherapies Key Players in Japan (2019-2020)
9.3 Japan Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
9.4 Japan Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Allergic Rhinitis Immunotherapies Market Size (2015-2020)
10.2 Allergic Rhinitis Immunotherapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
10.4 Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
11 INDIA
11.1 India Allergic Rhinitis Immunotherapies Market Size (2015-2020)
11.2 Allergic Rhinitis Immunotherapies Key Players in India (2019-2020)
11.3 India Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
11.4 India Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Allergic Rhinitis Immunotherapies Market Size (2015-2020)
12.2 Allergic Rhinitis Immunotherapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020)
12.4 Central & South America Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Anergis
13.1.1 Anergis Company Details
13.1.2 Anergis Business Overview and Its Total Revenue
13.1.3 Anergis Allergic Rhinitis Immunotherapies Introduction
13.1.4 Anergis Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020))
13.1.5 Anergis Recent Development
13.2 HAL Allergy Group
13.2.1 HAL Allergy Group Company Details
13.2.2 HAL Allergy Group Business Overview and Its Total Revenue
13.2.3 HAL Allergy Group Allergic Rhinitis Immunotherapies Introduction
13.2.4 HAL Allergy Group Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.2.5 HAL Allergy Group Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview and Its Total Revenue
13.3.3 Merck Allergic Rhinitis Immunotherapies Introduction
13.3.4 Merck Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Allergy Therapeutics
13.4.1 Allergy Therapeutics Company Details
13.4.2 Allergy Therapeutics Business Overview and Its Total Revenue
13.4.3 Allergy Therapeutics Allergic Rhinitis Immunotherapies Introduction
13.4.4 Allergy Therapeutics Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.4.5 Allergy Therapeutics Recent Development
13.5 ALK-Abello
13.5.1 ALK-Abello Company Details
13.5.2 ALK-Abello Business Overview and Its Total Revenue
13.5.3 ALK-Abello Allergic Rhinitis Immunotherapies Introduction
13.5.4 ALK-Abello Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.5.5 ALK-Abello Recent Development
13.6 Stallergenes Greer
13.6.1 Stallergenes Greer Company Details
13.6.2 Stallergenes Greer Business Overview and Its Total Revenue
13.6.3 Stallergenes Greer Allergic Rhinitis Immunotherapies Introduction
13.6.4 Stallergenes Greer Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.6.5 Stallergenes Greer Recent Development
13.7 Laboratorios LETI
13.7.1 Laboratorios LETI Company Details
13.7.2 Laboratorios LETI Business Overview and Its Total Revenue
13.7.3 Laboratorios LETI Allergic Rhinitis Immunotherapies Introduction
13.7.4 Laboratorios LETI Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020)
13.7.5 Laboratorios LETI Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Allergic Rhinitis Immunotherapies Key Market Segments
Table 2. Key Players Covered: Ranking by Allergic Rhinitis Immunotherapies Revenue
Table 3. Ranking of Global Top Allergic Rhinitis Immunotherapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Allergic Rhinitis Immunotherapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Subcutaneous Immunotherapy
Table 6. Key Players of Sublingual Immunotherapy
Table 7. COVID-19 Impact Global Market: (Four Allergic Rhinitis Immunotherapies Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Allergic Rhinitis Immunotherapies Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Allergic Rhinitis Immunotherapies Players to Combat Covid-19 Impact
Table 12. Global Allergic Rhinitis Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Allergic Rhinitis Immunotherapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Allergic Rhinitis Immunotherapies Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Allergic Rhinitis Immunotherapies Market Share by Regions (2015-2020)
Table 16. Global Allergic Rhinitis Immunotherapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Allergic Rhinitis Immunotherapies Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Allergic Rhinitis Immunotherapies Market Growth Strategy
Table 22. Main Points Interviewed from Key Allergic Rhinitis Immunotherapies Players
Table 23. Global Allergic Rhinitis Immunotherapies Revenue by Players (2015-2020) (Million US$)
Table 24. Global Allergic Rhinitis Immunotherapies Market Share by Players (2015-2020)
Table 25. Global Top Allergic Rhinitis Immunotherapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Rhinitis Immunotherapies as of 2019)
Table 26. Global Allergic Rhinitis Immunotherapies by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Allergic Rhinitis Immunotherapies Product Solution and Service
Table 29. Date of Enter into Allergic Rhinitis Immunotherapies Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 32. Global Allergic Rhinitis Immunotherapies Market Size Share by Type (2015-2020)
Table 33. Global Allergic Rhinitis Immunotherapies Revenue Market Share by Type (2021-2026)
Table 34. Global Allergic Rhinitis Immunotherapies Market Size Share by Application (2015-2020)
Table 35. Global Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 36. Global Allergic Rhinitis Immunotherapies Market Size Share by Application (2021-2026)
Table 37. North America Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 39. North America Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 40. North America Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 41. North America Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 42. North America Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 43. Europe Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 45. Europe Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 47. Europe Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 49. China Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 50. China Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 51. China Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 52. China Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 53. China Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 54. China Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 55. Japan Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 57. Japan Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 59. Japan Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 63. Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 65. Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 67. India Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 68. India Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 69. India Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 70. India Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 71. India Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 72. India Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 75. Central & South America Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 77. Central & South America Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 79. Anergis Company Details
Table 80. Anergis Business Overview
Table 81. Anergis Product
Table 82. Anergis Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 83. Anergis Recent Development
Table 84. HAL Allergy Group Company Details
Table 85. HAL Allergy Group Business Overview
Table 86. HAL Allergy Group Product
Table 87. HAL Allergy Group Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 88. HAL Allergy Group Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Allergy Therapeutics Company Details
Table 95. Allergy Therapeutics Business Overview
Table 96. Allergy Therapeutics Product
Table 97. Allergy Therapeutics Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 98. Allergy Therapeutics Recent Development
Table 99. ALK-Abello Company Details
Table 100. ALK-Abello Business Overview
Table 101. ALK-Abello Product
Table 102. ALK-Abello Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 103. ALK-Abello Recent Development
Table 104. Stallergenes Greer Company Details
Table 105. Stallergenes Greer Business Overview
Table 106. Stallergenes Greer Product
Table 107. Stallergenes Greer Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 108. Stallergenes Greer Recent Development
Table 109. Laboratorios LETI Company Details
Table 110. Laboratorios LETI Business Overview
Table 111. Laboratorios LETI Product
Table 112. Laboratorios LETI Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 113. Laboratorios LETI Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 1. Allergic Rhinitis Immunotherapies Key Market Segments
Table 2. Key Players Covered: Ranking by Allergic Rhinitis Immunotherapies Revenue
Table 3. Ranking of Global Top Allergic Rhinitis Immunotherapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Allergic Rhinitis Immunotherapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Subcutaneous Immunotherapy
Table 6. Key Players of Sublingual Immunotherapy
Table 7. COVID-19 Impact Global Market: (Four Allergic Rhinitis Immunotherapies Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Allergic Rhinitis Immunotherapies Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Allergic Rhinitis Immunotherapies Players to Combat Covid-19 Impact
Table 12. Global Allergic Rhinitis Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Allergic Rhinitis Immunotherapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Allergic Rhinitis Immunotherapies Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Allergic Rhinitis Immunotherapies Market Share by Regions (2015-2020)
Table 16. Global Allergic Rhinitis Immunotherapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Allergic Rhinitis Immunotherapies Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Allergic Rhinitis Immunotherapies Market Growth Strategy
Table 22. Main Points Interviewed from Key Allergic Rhinitis Immunotherapies Players
Table 23. Global Allergic Rhinitis Immunotherapies Revenue by Players (2015-2020) (Million US$)
Table 24. Global Allergic Rhinitis Immunotherapies Market Share by Players (2015-2020)
Table 25. Global Top Allergic Rhinitis Immunotherapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Rhinitis Immunotherapies as of 2019)
Table 26. Global Allergic Rhinitis Immunotherapies by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Allergic Rhinitis Immunotherapies Product Solution and Service
Table 29. Date of Enter into Allergic Rhinitis Immunotherapies Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 32. Global Allergic Rhinitis Immunotherapies Market Size Share by Type (2015-2020)
Table 33. Global Allergic Rhinitis Immunotherapies Revenue Market Share by Type (2021-2026)
Table 34. Global Allergic Rhinitis Immunotherapies Market Size Share by Application (2015-2020)
Table 35. Global Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 36. Global Allergic Rhinitis Immunotherapies Market Size Share by Application (2021-2026)
Table 37. North America Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 39. North America Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 40. North America Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 41. North America Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 42. North America Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 43. Europe Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 45. Europe Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 47. Europe Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 49. China Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 50. China Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 51. China Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 52. China Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 53. China Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 54. China Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 55. Japan Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 57. Japan Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 59. Japan Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 63. Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 65. Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 67. India Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 68. India Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 69. India Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 70. India Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 71. India Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 72. India Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Allergic Rhinitis Immunotherapies Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Allergic Rhinitis Immunotherapies Market Share (2019-2020)
Table 75. Central & South America Allergic Rhinitis Immunotherapies Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Allergic Rhinitis Immunotherapies Market Share by Type (2015-2020)
Table 77. Central & South America Allergic Rhinitis Immunotherapies Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Allergic Rhinitis Immunotherapies Market Share by Application (2015-2020)
Table 79. Anergis Company Details
Table 80. Anergis Business Overview
Table 81. Anergis Product
Table 82. Anergis Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 83. Anergis Recent Development
Table 84. HAL Allergy Group Company Details
Table 85. HAL Allergy Group Business Overview
Table 86. HAL Allergy Group Product
Table 87. HAL Allergy Group Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 88. HAL Allergy Group Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Allergy Therapeutics Company Details
Table 95. Allergy Therapeutics Business Overview
Table 96. Allergy Therapeutics Product
Table 97. Allergy Therapeutics Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 98. Allergy Therapeutics Recent Development
Table 99. ALK-Abello Company Details
Table 100. ALK-Abello Business Overview
Table 101. ALK-Abello Product
Table 102. ALK-Abello Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 103. ALK-Abello Recent Development
Table 104. Stallergenes Greer Company Details
Table 105. Stallergenes Greer Business Overview
Table 106. Stallergenes Greer Product
Table 107. Stallergenes Greer Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 108. Stallergenes Greer Recent Development
Table 109. Laboratorios LETI Company Details
Table 110. Laboratorios LETI Business Overview
Table 111. Laboratorios LETI Product
Table 112. Laboratorios LETI Revenue in Allergic Rhinitis Immunotherapies Business (2015-2020) (Million US$)
Table 113. Laboratorios LETI Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Allergic Rhinitis Immunotherapies Market Share by Type: 2020 VS 2026
Figure 2. Subcutaneous Immunotherapy Features
Figure 3. Sublingual Immunotherapy Features
Figure 4. Global Allergic Rhinitis Immunotherapies Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Allergic Rhinitis Immunotherapies Report Years Considered
Figure 9. Global Allergic Rhinitis Immunotherapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Allergic Rhinitis Immunotherapies Market Share by Regions: 2020 VS 2026
Figure 11. Global Allergic Rhinitis Immunotherapies Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Allergic Rhinitis Immunotherapies Market Share by Players in 2019
Figure 14. Global Top Allergic Rhinitis Immunotherapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Rhinitis Immunotherapies as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Allergic Rhinitis Immunotherapies Revenue in 2019
Figure 16. North America Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Anergis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Anergis Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 25. HAL Allergy Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. HAL Allergy Group Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 27. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Merck Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 29. Allergy Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Allergy Therapeutics Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 31. ALK-Abello Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ALK-Abello Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 33. Stallergenes Greer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Stallergenes Greer Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 35. Laboratorios LETI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Laboratorios LETI Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed
Figure 1. Global Allergic Rhinitis Immunotherapies Market Share by Type: 2020 VS 2026
Figure 2. Subcutaneous Immunotherapy Features
Figure 3. Sublingual Immunotherapy Features
Figure 4. Global Allergic Rhinitis Immunotherapies Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Allergic Rhinitis Immunotherapies Report Years Considered
Figure 9. Global Allergic Rhinitis Immunotherapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Allergic Rhinitis Immunotherapies Market Share by Regions: 2020 VS 2026
Figure 11. Global Allergic Rhinitis Immunotherapies Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Allergic Rhinitis Immunotherapies Market Share by Players in 2019
Figure 14. Global Top Allergic Rhinitis Immunotherapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Rhinitis Immunotherapies as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Allergic Rhinitis Immunotherapies Revenue in 2019
Figure 16. North America Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Allergic Rhinitis Immunotherapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Anergis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Anergis Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 25. HAL Allergy Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. HAL Allergy Group Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 27. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Merck Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 29. Allergy Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Allergy Therapeutics Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 31. ALK-Abello Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ALK-Abello Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 33. Stallergenes Greer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Stallergenes Greer Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 35. Laboratorios LETI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Laboratorios LETI Revenue Growth Rate in Allergic Rhinitis Immunotherapies Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed
